Drug cuts relapse rate of C. diff infection
Friday 04 February 2011
A new antibiotic has been shown to cut the rate of relapse by almost half of infections of the C. difficile bacterium, a growing scourge in hospitals worldwide, a study published Wednesday indicates.
The researchers examined a drug called Fidaxomicin, made by Optimer Pharmaceuticals of San Diego, and compared it to the antibiotic vancomycin, the only treatment against the infection approved in the United States and Canada.
By following 629 subjects over two years in a randomized study in which patients received one of the two treatments, those who took Fidaxomicin saw a 45 percent reduction in recurrences.
"Anybody who knows C. difficile recognizes that recurrences are the major problem with this disease," said Mark Miller of the Jewish General Hospital in Montreal, a co-author of the study in the New England Journal of Medicine.
"Anything that can reduce the recurrence rate, especially as dramatically as Fidaxomicin, is a very important milestone in the treatment of C. difficile."
C. difficile, which can cause anything from mild diarrhea to deadly colon inflammation, tends to afflict people in hospitals or long-term care facilities and can take hold after a patient has been on antibiotics.
Cases have been mounting in the past decade and 20 to 30 percent of patients who suffer from it once will get it again. Recurrent C diff is particularly hard to treat.
"There wasn't much interest in C. difficile for many years, because it wasn't considered a serious disease," said Miller.
"However, over the past decade the bacterium has mutated into something much more serious that has caused epidemics worldwide. It is particularly notorious for recurrences."
Fidaxomicin works by targeting bacteria inside the intestine and is minimally absorbed in the blood stream, so it kills the C. diff "without affecting the beneficial flora in the human gut which help stave off recurrences," the study said.
Life & Style blogs
Earth Day 2014: Google celebrates Earth Day with doodles of Rufous hummingbird, veiled chameleon, moon jellyfish, dung beetle, puffer fish and macaques
Naked yoga: the bare truth - it's already big in the US, and has now landed here
World's fastest lift climbs 95 floors in 43 seconds at speeds of up to 45mph
A bottle of wine a day is not bad for you and abstaining is worse than drinking, scientist claims
Saint George's Day: Google Doodle marks England's national day
- 1 Revealed: Scientists ‘edit’ DNA to correct adult genes and cure diseases
- 2 David Cameron's constituency office calls police on food bank campaigners Bishop of Oxford and Reverend Keith Hebden
- 3 A bottle of wine a day is not bad for you and abstaining is worse than drinking, scientist claims
- 4 Women take on Bear Grylls over 'sexist' male-only desert island show
- 5 Malaysia Airlines flight MH370: Concerns grow among search officials that missing jet ‘may have landed somewhere else’
Very Competitive: Austen Lloyd: Clinical Negligence - Oxford An opportunity f...
£55000 - £62000 per annum + outstanding benefits and bonus: Pro-Recruitment Gr...
£120 per day: Randstad Education Luton: Reception teacher required for an Outs...
£35000 - £45000 per annum + excellent company benefits : Pro-Recruitment Group...